digital transformation

“Exact Sciences' innovation, its strong brand and customer-focused execution are unrivaled in the cancer diagnostics space, and its presence and strengths are complementary to our own. Abbott has repeatedly taken on the world's most challenging health issues and made a meaningful impact on the lives of people in areas such as diabetes, cardiovascular disease and infectious diseases.”

“Together with Abbott, we can reach more patients, advance earlier detection, and deliver answers that change lives. Abbott's culture of innovation and global commercial reach will help accelerate our mission of eradicating cancer and expanding access to our tests worldwide.”

“Our Aon United strategy, accelerated through our 3x3 Plan, is delivering strong results. We are attracting top talent in high-growth areas, scaling our data analytics across our core Risk Capital and Human Capital businesses, expanding in the middle market and unlocking new sources of capital.”

“Our strong capital position, fueled by robust cash generation and disciplined portfolio management, enables us to execute our capital allocation model — balancing high-return investment for future growth and capital return to shareholders.”

“We remain confident in achieving our full-year 2025 financial targets and are well positioned to deliver sustainable growth in 2026 and beyond.”

“This acquisition represents a compelling strategic fit and a meaningful expansion of A. O. Smith's presence in the water management market.”

If you're building health tech or digital health engagement tools, CVS is investing heavily in an open consumer engagement platform — that's either a distribution partner or a well-funded competitor coming for your market.

If you're building anything in the value-retail or membership economy space, this is validation that consumers are consolidating spend toward trusted, high-value platforms. Membership fee growth post-increase means pricing power is real when the value prop is clear.

If you sell into automotive OEMs, budget cycles are getting longer and more complex as suppliers like Aptiv restructure. But if you build edge AI, robotics, or industrial automation solutions, Aptiv's aggressive pivot into non-auto markets signals real demand from a $12B+ buyer willing to invest organically and via M&A.

If you're building on cloud infrastructure, Oracle is aggressively competing on price and availability with 211+ regions. Their multicloud strategy means your enterprise customers may start requesting Oracle database deployments inside their existing AWS/Azure environments — be ready to support that.

If you're building insurtech or selling into risk management budgets, the spend environment is healthy — Aon's broad-based growth signals enterprise buyers are actively investing in risk and benefits advisory, not cutting.

If you're building on or competing with Shopify's ecosystem, their merchant solutions flywheel is accelerating — they're monetizing the full commerce stack, not just storefronts. Build where they aren't yet or prepare to be bundled.

If you're selling into water or municipal infrastructure, budget cycles are expanding not contracting — Xylem's organic growth acceleration and raised guidance signal that utilities and industrial buyers are spending through macro uncertainty.

If you're selling into retail or supply chain digitization, the RFID/intelligent labels wave is real and accelerating — Avery's Solutions Group growth confirms enterprise buyers are actively spending here even as broader materials demand softens.

If you're building custom silicon or AI accelerators, Cadence's expanding portfolio and AI-centric tools mean the design toolchain is getting richer — budget for deeper EDA spend but expect faster tapeout cycles.

If you're building security tools, CrowdStrike's platform consolidation play is swallowing adjacent categories fast — cloud security, identity, SIEM. Either integrate with Falcon or find a niche they haven't reached yet. If you're a buyer, Falcon Flex pricing creates real consolidation leverage worth evaluating.

If you're building in proptech or adjacent to real estate marketplaces, CoStar is flooding the zone with capital and AI-powered search. Their Homes.com network at 115M monthly uniques makes them a platform you either integrate with or get steamrolled by.

If you're building in the SMB/mid-market CRM or marketing automation space, HubSpot is pulling away. Their AI agent strategy is creating switching costs — the window to win customers before they consolidate onto HubSpot is narrowing.

If you're building for public safety or enterprise physical security, Axon is consolidating the stack fast — from body cams to 911 dispatch to drones. Either integrate into their ecosystem or prepare to compete against a $2.7B-revenue platform with $11.4B in contracted backlog.

If you're building in rural connectivity or carrier-managed services, ATN's expansion signals growing demand in underserved markets — but the pace is methodical, not explosive. Budget cycles here are long.

If you're building in diagnostics, cancer screening, or precision oncology, Abbott just became a much bigger competitor with $12B+ in annual diagnostics revenue post-close. Exact Sciences' distribution will accelerate under Abbott's 160-country footprint.

If you're building connected building infrastructure or selling into healthcare/education facilities, A. O. Smith is aggressively expanding its mechanical-room footprint — expect them as a bundled competitor for water management systems.

If you sell into enterprise IT, IBM's clients are spending — especially on AI transformation and infrastructure modernization. The z17 cycle and AI consulting demand signal real budget allocation, not just pilots. Position your product as part of the AI deployment stack, not a net-new budget line.

Intuit consolidating its consumer-facing businesses signals a platform play — expect bundled offerings across tax, credit, and personal finance that raise switching costs for end users and squeeze standalone competitors in each vertical.